4-Chloroazetidinone-1-(2',3'-dichloroisopropyl) acetates and process for preparing same
AssigneeConnlab Holdings Limited
InventorsRonald G. Micetich, Robert B. Morin, Kenneth E. Wilson
Life of this patent
Estimating the term…
Loading patent…
AssigneeConnlab Holdings Limited
InventorsRonald G. Micetich, Robert B. Morin, Kenneth E. Wilson
Estimating the term…
The invention relates to novel azetidinones of the general formula: ##STR1## wherein R stands for lower alkyl, phenyl, phenyloxyloweralkyl, phenylloweralkyl, 2-thiophenemethyl, 5-tetrazolylmethyl, R.sup.3 O--and R.sup.3 S--, wherein R.sup.3 stands for lower alkyl, phenyl or phenylloweralkyl; R.sup.1 is hydrogen or a cleavable radical selected from lower alkyl; loweralkoxymethyl, 2,2,2-trichloroethyl, benzyl, p-halobenzyl, p-nitrobenzyl and p-methoxybenzyl, benzhydryl and trimethylsilyl; R.sup.2 is hydrogen or methoxy; X is SCl, Sbr or --OH in which case the C.sub.3 -sidechain is better represented as the amide RCONH-- group; Y is chloro or bromo; and ##STR2## may also be taken as phthalimido. These novel compounds possess antibacterial activity and are useful intermediates for the synthesis of modified penicillins and the analogues of penicillins.
A compound of the general formula:
The methyl 3S-phenoxycarbamido-4S-chloroazetidinone-1-.alpha.(.beta.-chloromethyl-.be ta.-chloro)butyrate.
The methyl 3S-phenoxyacetamido-4S-chloroazetidinone-1-.alpha.(.beta.-chloromethyl-.be ta.-chloro)butyrate.
Dependencies are inferred from the claim text.